Hypozincemia in the early stage of COVID-19 is associated with an increased risk of severe COVID-19.
Fiche publication
Date publication
mai 2021
Journal
Clinical nutrition (Edinburgh, Scotland)
Auteurs
Membres identifiés du Cancéropôle Est :
Pr GUEANT Jean-Louis
Tous les auteurs :
Fromonot J, Gette M, Ben Lassoued A, Guéant JL, Guéant-Rodriguez RM, Guieu R
Lien Pubmed
Résumé
Nutritional predisposition to severe coronavirus disease 2019 (COVID-19) remains unclear. Zinc deficiency could be critical since it is associated with a higher susceptibility to infections. We evaluated the prevalence of hypozincemia in the early stage of COVID-19, its association with risk factors for severe COVID-19 and its prognostic value for hospitalization for respiratory complications within 10 days.
Mots clés
COVID-19, Inflammation, Lymphopenia, Risk factor, Selenium, Zinc
Référence
Clin Nutr. 2021 May 4;: